Stock Market Today, March: CytomX Surges on Positive Data
CytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
Knowing when to invest with your savings can significantly impact your returns. Explore the best timing strategies for your investments.
17,373 articlesCytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
A 5% pullback in the Nasdaq in 2026 echoes big past moves and offers clues about which stocks tend to fare best durin...
Biotech earnings season shines a spotlight on Delcath Systems. This guide breaks down the 2026 earnings outlook, key ...
May brings renewed focus on national security and market resilience. This guide identifies a top defense stock and sh...
A dramatic 41% weekly jump has investors buzzing about Infleqtion. Learn what fueled the move, how to evaluate quantu...
Investors face a pivotal choice in 2026: a dependable defense powerhouse or a cyclical recovery in commercial aviatio...
Tired of trying to time the market? This guide shows a simple, proven path: buy solid dividend stocks and hold them f...
SpaceX kicked off trading with a sharp first-day rally. This guide analyzes historical IPO patterns to estimate where...
Is DraftKings stock analysis signaling a sell or a hold? This deep dive breaks down how regulation, competition, and ...
As SpaceX moves deeper into the public market, investors face a volatile ride. This article lays out credible scenari...
SpaceX raised $25 billion through a bond offering that received top ratings from credit agencies, yet the stock still...
A Paychex insider recently moved tens of thousands of shares, prompting questions about the stock’s trajectory. This ...